-
Handling Highly Active Ingredients
that offered containment levels between those of gloveboxes and those of cleanrooms, at costs approaching those of cleanrooms. The term for the equipment was questionable at best, since barriers and isolators do. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical...
-
Handling Highly Active Ingredients
operation to the next, and, most interestingly, through flexible-film mini-enclosures that minimize cleaning and related validation. System designs reflect increased a focus on meeting occupational exposure. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical...
-
Handling Highly Active Ingredients
Durney, director for new business development at ILC Dover (Frederica, Del.), claims the cost savings from disposable PPE alone more than offsets the. Containment: Handling Highly Active Ingredients | Engineering & Processing | Pharmaceutical Manufacturing. Digital Magazine: Read / Subscribe. RSS...
-
Phenom Use for Pharmaceutical Inspection (.pdf)
film-forming and. Production of a solid drug dosage form typically begins with. dispersing action properties. Figure 2 provides excellent. the formation of an active pharmaceutical ingredient (API). views of the sponge-like structure of Kollidon Cl which allows. into particles, generally within the range...
-
3-A to Develop Pharmaceutical Industry Standards
Already frequently cited for pharmaceutical industry applications, 3-A Sanitary Standards, Inc., McLean, Va., has announced plans to develop a line of standards specifically for equipment used in the manufacture of active pharmaceutical ingredients (APIs). The new standards, to be called P3-A...
-
Pharmaceutical Application for Water Activity (.pdf)
Knowledge of the water activity of pharmaceutical solids (proteins, drugs, and excipients) is essential to obtain a solid dosage form with optimal chemical, physical, microbial and shelf-life properties. Water activity (aw) influences the chemical stability, microbial stability, flow properties...
-
Contract Research in China: A Catalyst for Pharmaceutical Industry Growth
for marketing approval in China.. ADVERTISEMENT. Contract manufacturing was one of the first growth areas in Chinese pharmaceuticals. Since the early 1990s, an increasing number of Chinese Contract Manufacturing Organizations (CMOs) have engaged in Active Pharmaceutical Ingredient (API) production...
-
Contract Research in China: A Catalyst for Pharmaceutical Industry Growth
in Chinese pharmaceuticals. Since the early 1990s, an increasing number of Chinese Contract Manufacturing Organizations (CMOs) have engaged in Active Pharmaceutical Ingredient (API) production, and many are endeavoring to meet international production standards for finished drugs. In 2004, Chinese CMOs...
-
IFPAC Conference Highlights Pharmaceutical Applications of PAT
. Laurie St. Pierre Berry, PAT specialist at Pfizer's Groton, Conn., plant described her company's use of NIR as well as infrared (IR) and reduction-oxidation techniques. "New PAT strategies are being implemented into API [active pharmaceutical ingredient] facilities for controlling and monitoring...
-
Getting the Most from Coriolis Flowmeters in Pharmaceutical Processes
of Pharmaceutical Processes There are numerous opportunities for flow measurement devices during the chemical synthesis phase of production, which is characterized by large- to small-scale production of the Active Pharmaceutical Ingredient (API). Often, large quantities of raw materials must be received from...